This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nrg Therapeutics Ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christopher Thomson - Innovator in mPTP Inhibitors
Introduction
Christopher Thomson is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for the mitochondrial permeability transition pore (mPTP). His innovative work has the potential to impact various therapeutic areas.
Latest Patents
Christopher Thomson holds 1 patent related to his invention titled "Inhibitors of mPTP." This invention pertains to compounds of formula (I) and explores various related aspects that could lead to advancements in medical treatments.
Career Highlights
Thomson is currently associated with NRG Therapeutics Ltd, where he continues to push the boundaries of scientific research. His work at the company focuses on developing novel therapeutic strategies that target critical cellular processes.
Collaborations
He has collaborated with notable colleagues, including Neil Miller and Richard Rutter, to further enhance the research and development efforts in their field.
Conclusion
Christopher Thomson's contributions to the field of mPTP inhibitors exemplify the innovative spirit of modern science. His work not only showcases his expertise but also holds promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile